Effects of Subcutaneous and Intravenous Recombinant Human Erythropoietin Treatments on Body Iron in Rats
Recombinant human erythropoietin (rHuEPO) is used widely in clinical practice for correcting anemia related to renal failure, cancer chemotherapy, HIV infection, premature infants, and chronic diseases. Recombinant human erythropoietin is known to affect body iron status that may result in functiona...
Saved in:
| 主要作者: | |
|---|---|
| 格式: | Thesis |
| 語言: | English English |
| 出版: |
2009
|
| 主題: | |
| 在線閱讀: | http://psasir.upm.edu.my/id/eprint/11540/1/FPV_2009_15.pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|